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background:  Multiple risk prediction models are available for to identify individuals at risk of coronary artery disease (CAD). Prior data 
suggested the Framingham risk score (FRS) underestimate the risk for CAD. The aim of this analysis is to compare the utility of the ACC/
AHA Pooled Cohort Risk Equation in the identification of high-risk individuals at risk of developing myocardial infraction (MI).
Methods:  This is a retrospective analysis of 1,981 patients (Mean age 60 years, 21% females) hospitalized for their first acute myocardial 
infarction (AMI) between 2010 and 2013. Patients with prior CAD or heart failure were excluded. The FRS and the new ACC/AHA Pooled 
Cohort Equations Risk Estimatorwas calculated for the study cohort and compared.
Results:  Using clinical characteristics and lipid profile obtained just before these patients developed symptoms, 11%, 65% and 24% were 
classified as low, intermediate and high risk per the FRS respectively. When the new ACC/AHA score was used, 14%, 9% and 76% were 
classified as low, intermediate and high risk respectively (p<0.0001). The re-classification per group is shown in the figure below.
conclusion:  The new ACC/AHA risk score classifies a higher percentage of patients who develops MI as high risk. Whether using the new 
risk to identify patients in whom intensive pharmacotherapy reduces the risk of future MI is to be determined.
 
